Reply to 'Letter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination'

QJM. 2022 Jul 9;115(7):500-501. doi: 10.1093/qjmed/hcab232.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Coronary Vessels
  • Humans
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • Troponin
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Troponin